09. December 2009Roche introduces new automated clinical laboratory system for CE-Marked testing of human papillomavirus, Chlamydia and N. gonorrhoeaeRoche announced the launch of a new clinical laboratory system designed to increase laboratory testing efficiency and to accommodate current and long-term molecular diagnostic needs.more 02. December 2009FDA approves use of Roche test to screen source plasma for HIV, hepatitis B virus and hepatitis C virusRoche announced that the United States FDA approved an additional intended use for its licensed nucleic acid test, to screen source plasma in pools comprised of up to 96 individual donations. The test, called the cobas® TaqScreen MPX Test ...more 28. October 2009Roche introduces new cobas p 630 Instrument and AMPLILINK 3.3 Series Software with CE MarkRoche Molecular Diagnostics announced the availability of the cobas p 630 Instrument with CE Mark and the AMPLILINK 3.3 Series Software. more 02. April 2009Roche to introduce new LightCycler® MRSA Advanced Test in the EURoche announced that its new LightCycler® test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) is now available with the CE Mark, allowing it to be sold for clinical use in the European Union. more |